Predictors of Increased Intravenous Tissue Plasminogen Activator Use Among Hospitals Participating in the Massachusetts Primary Stroke Service Program | Zendy

Natalia S. Rost | Zendy; Eric E. Smith | Zendy; Muhammad A. Pervez | Zendy; Philip Mello | Zendy; Paul Dreyer | Zendy; Lee H. Schwamm | Zendy

Open Access

Predictors of Increased Intravenous Tissue Plasminogen Activator Use Among Hospitals Participating in the Massachusetts Primary Stroke Service Program

Author(s) -

Natalia S. Rost,

Eric E. Smith,

Muhammad A. Pervez,

Philip Mello,

Paul Dreyer,

Lee H. Schwamm

Publication year - 2012

Publication title -

circulation cardiovascular quality and outcomes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.692

H-Index - 87

eISSN - 1941-7705

pISSN - 1941-7713

DOI - 10.1161/circoutcomes.111.962829

Subject(s) - medicine , stroke (engine) , tissue plasminogen activator , emergency department , emergency medicine , thrombolysis , fibrinolytic agent , myocardial infarction , mechanical engineering , psychiatry , engineering

We sought to determine if intravenous tissue plasminogen activator (IV tPA) use for acute ischemic stroke increased in Massachusetts in association with the Primary Stroke Service program, a statewide stroke center designation and quality improvement initiative.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research